HOME >> BIOLOGY >> NEWS
Inflammation markers identify fatigue in breast cancer survivors

PHILADELHPIA -- Researchers at the University of California, Los Angeles have defined conditions associated with disabling fatigue that persists for years in almost a third of breast cancer survivors, according to a study in the May 1 issue of Clinical Cancer Research.

The key to their fatigue stems from responses within their immune systems.

"These studies identify a biological basis for persistent fatigue in cancer survivors that is implemented by inflammation," said Michael Irwin, M.D., director and senior research scientist, Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience, and the UCLA Jonsson Cancer Center.

"We have detected a biological marker that is a composite of two immune response elements," he added. "This biomarker identifies and can predict which women have long term persistent fatigue.

"These findings point the way for development of novel treatment strategies that decrease this inflammatory response and thwart the fatigue that these patients endure."

One component of the marker, Dr. Irwin explained, is a measure of the amount of interleukin-6 receptor (IL-6R) free-floating in the blood of breast cancer survivors compared to the amount of that receptor remaining on the membranes of specific blood cells where the receptor normally is found and functions within the immune response.

The IL-6R is usually embedded on the surface membrane of white blood cells, or monocytes. In some survivors, however, many of the IL-6R are shed from the monocytes and are soluble within the blood plasma. Those free-floating receptors can still bind to circulating cytokine IL-6, Dr. Irwin noted, and in that form have the potential to interact with cells that normally don't respond to cytokine/receptor activation such as brain cells that may regulate fatigue sensation.

IL6 is a biological chemical that helps drive initial immune responses within people. "IL-6 contribut
'"/>

Contact: Russell Vanderboom, Ph.D.
vanderboom@aacr.org
215-440-9300
American Association for Cancer Research
1-May-2006


Page: 1 2

Related biology news :

1. Inflammation may cause preterm labor and fetal deaths
2. Inflammation is at the origin and progression of diseases such as diabetes or cancer
3. Targeting tau: Inflammation study suggests new approach for fighting Alzheimers
4. Inflammation and drugs to control this activity studied in a variety of tumors sites
5. Research aims to identify markers for menopausal women at risk for deadly blood clot
6. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
7. New tumor markers -- Spot the differences
8. Tumor vessels identified by unique molecular markers
9. Jaap Sinninghe Damst awarded the Vernadsky Medal for innovative use of biomarkers
10. Pancreatic cancer markers identified, may predict survival
11. Genes and biomarkers that allow doctors to choose the right therapy for the right patient

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... ... August 06, 2019 , ... The demand for plant-based foods ... particular quickly entered the limelight – meat alternatives. Yet, to make these meat ... ingredient such as methyl cellulose. This ingredient is highly synthetic. Having a stabilized ...
(Date:8/1/2019)... ... July 30, 2019 , ... Keck Graduate Institute (KGI) President ... Professor in Bioprocessing and Director of the Amgen Bioprocessing Center, effective July 29, ... and possesses more than 25 years of global experience in bioprocessing,” Schuster said. ...
(Date:7/26/2019)... , ... July 25, 2019 , ... ... announced the first mixed reality headsets to include a new generation eye tracker ... Exhibition in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is the market ... Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the ... Market for Point-of-Care (POC) Diagnostics . , Quidel is a market leader in ...
(Date:7/9/2019)... DES MOINES, Iowa (PRWEB) , ... July 08, 2019 , ... ... in Des Moines, Iowa, the National Corn Growers Association (NCGA) announced the ... unique technology to improve a product or process using field corn to produce biobased ...
(Date:7/2/2019)... ... 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , ... The film focuses on regenerative veterinary medicine as a means of improving the ... included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, ...
(Date:6/18/2019)... and SOMERSET, N.J. (PRWEB) , ... June 17, ... ... Biologics, today announced that they have entered into an agreement for production and ... candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and ...
Breaking Biology Technology:
Cached News: